by McKesson Ventures | Jul 7, 2020 | Portfolio News
While COVID-19 has justifiably been at the top of healthcare news, a major medical breakthrough has been quietly happening in the San Francisco Bay area—one that could detect another potentially fatal disease before it’s too late: Cancer. And the company responsible...
by McKesson Ventures | Jun 24, 2020 | Portfolio News
McKesson Ventures portfolio company Hims & Hers is one of the first 12 national companies signing on to a pledge to guarantee employee birth control coverage, whether or not they are required to do so by law. Currently, under the Affordable Care Act, most...
by McKesson Ventures | Jun 24, 2020 | Portfolio News
On June 24, 2020, Accolade set the terms for its IPO. The startup will price 8.75 million shares at between $19 and $21, raising as much as $211 million. If it succeeds in raising that amount of money, its valuation will rise to around $1 billion. It will trade on the...
by McKesson Ventures | Jun 16, 2020 | Portfolio News
Proteus Digital Health, the maker of an ingestible sensor for tracking medication adherence, filed for Chapter 11 bankruptcy protection on June 15, 2020. In addition, Andrew Thompson stepped down as the company’s CEO, replaced by Lawrence Perkins of...
by McKesson Ventures | Jun 15, 2020 | Portfolio News
Walmart is acquiring technology and intellectual property from CareZone, a startup that makes it easier for people to manage multiple medications, Walmart confirmed to CNBC. CareZone got its start in 2010. It develops apps to help people manage their medicines. The...
by McKesson Ventures | Jun 15, 2020 | Portfolio News
Augmedix has announced that Jennifer M. Carter, Vice President, Venture Operations at McKesson Ventures, will join its board of directors. At McKesson Ventures, Carter leads a team responsible for investing, fund management, portfolio development, marketing, and PR....
